4.8 Review

Controlling the Immune Suppressor: Transcription Factors and MicroRnAs Regulating CD73/NT5E

期刊

FRONTIERS IN IMMUNOLOGY
卷 9, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2018.00813

关键词

checkpoint molecule; CD73; NT5E; microRNA; transcription factor; T cell; tumor; A2A receptor

向作者/读者索取更多资源

The NT5E (CD73) molecule represents an ecto-5'-nucleotidase expressed on the cell surface of various cell types. Hydrolyzing extracellular adenosine monophosphate into adenosine and inorganic phosphate, NT5E performs numerous homeostatic functions in healthy organs and tissues. Importantly, NT5E can act as inhibitory immune checkpoint molecule, since free adenosine generated by NT5E inhibits cellular immune responses, thereby promoting immune escape of tumor cells. MicroRNAs (miRNAs) are small non-coding RNA molecules regulating gene expression on posttranscriptional level through binding to mRNAs, resulting in translational repression or degradation of the targeted mRNA molecule. In tumor cells, miRNA expression patterns are often altered which in turn might affect NT5E surface expression and eventually influence the efficacy of antitumor immune responses. This review describes the diverse roles of NT5E, summarizes current knowledge about transcription factors controlling NT5E expression, and highlights the significance of miRNAs involved in the posttranscriptional regulation of NT5E expression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival

Adi Sharbi-Yunger, Mareike Grees, Gal Cafri, David Bassan, Stefan B. Eichmuller, Esther Tzehoval, Jochen Utikal, Viktor Umansky, Lea Eisenbach

INTERNATIONAL JOURNAL OF CANCER (2019)

Article Oncology

Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status

Dominik S. Gangkofner, Dana Holzinger, Lea Schroeder, Stefan B. Eichmueller, Inka Zoernig, Dirk Jaeger, Gunnar Wichmann, Andreas Dietz, Martina A. Broglie, Christel Herold-Mende, Gerhard Dyckhoff, Paolo Boscolo-Rizzo, Jasmin Ezic, Ralf B. Marienfeld, Peter Moeller, Gunnar Voelkel, Johann M. Kraus, Hans A. Kestler, Cornelia Brunner, Patrick J. Schuler, Marlene Wigand, Marie N. Theodoraki, Johannes Doescher, Thomas K. Hoffmann, Michael Pawlita, Julia Butt, Tim Waterboer, Simon Laban

INTERNATIONAL JOURNAL OF CANCER (2019)

Article Virology

Measles Vaccines Designed for Enhanced CD8+ T Cell Activation

Elena Busch, Kristina D. Kubon, Johanna K. M. Mayer, Gemma Pidelaserra-Marti, Jessica Albert, Birgit Hoyler, Johannes P. W. Heidbuechel, Kyle B. Stephenson, Brian D. Lichty, Wolfram Osen, Stefan B. Eichmueller, Dirk Jaeger, Guy Ungerechts, Christine E. Engeland

VIRUSES-BASEL (2020)

Article Multidisciplinary Sciences

Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line

Philipp Schroeter, Laura Hartmann, Wolfram Osen, Daniel Baumann, Rienk Offringa, David Eisel, Juergen Debus, Stefan B. Eichmueller, Stefan Rieken

SCIENTIFIC REPORTS (2020)

Article Biochemical Research Methods

Reprogramming of macrophages employing gene regulatory and metabolic network models

Franziska Hoerhold, David Eisel, Marcus Oswald, Amol Kolte, Daniela Roell, Wolfram Osen, Stefan B. Eichmueller, Rainer Koenig

PLOS COMPUTATIONAL BIOLOGY (2020)

Article Oncology

Cost of decentralizedCART-cell production in an academic nonprofit setting

Tao Ran, Stefan B. Eichmueller, Patrick Schmidt, Michael Schlander

INTERNATIONAL JOURNAL OF CANCER (2020)

Letter Oncology

Reply to: Comments on Cost of decentralizedCART cell production in an academic non-profit setting

Tao Ran, Stefan B. Eichmueller, Patrick Schmidt, Michael Schlander

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Multidisciplinary Sciences

Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell lines

Laura Hartmann, Philipp Schroeter, Wolfram Osen, Daniel Baumann, Rienk Offringa, Mahmoud Moustafa, Rainer Will, Juergen Debus, Stephan Brons, Stefan Rieken, Stefan B. Eichmueller

SCIENTIFIC REPORTS (2020)

Article Oncology

T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas

Michael Kilian, Mirco Friedrich, Khwab Sanghvi, Edward Green, Stefan Pusch, Daisuke Kawauchi, Martin Loewer, Jana K. Sonner, Christopher Kraemer, Julia Zaman, Stefanie Jung, Michael O. Breckwoldt, Gerald Willimksy, Stefan B. Eichmueller, Andreas von Deimling, Wolfgang Wick, Felix Sahm, Michael Platten, Lukas Bunse

Summary: In this study, glioma-specific immunogenic neoepitopes were identified using peptide-based ELISpot assays and droplet-based single-cell TCR sequencing in MHC-humanized mice. The efficacy of TCR-transgenic T-cell therapy against gliomas was demonstrated in a humanized orthotopic glioma model.

CLINICAL CANCER RESEARCH (2022)

Article Cell & Tissue Engineering

Antigen presentation safeguards the integrity of the hematopoietic stem cell pool

Pablo Hernandez-Malmierca, Dominik Vonficht, Alexandra Schnell, Hannah J. Uckelmann, Alina Bollhagen, Mohamed A. A. Mahmoud, Sophie-Luise Landua, Elise van der Salm, Christine L. Trautmann, Simon Raffel, Florian Gruenschlaeger, Raphael Lutz, Michael Ghosh, Simon Renders, Nadia Correia, Elisa Donato, Karin O. Dixon, Christoph Hirche, Carolin Andresen, Claudia Robens, Paula S. Werner, Tobias Boch, David Eisel, Wolfram Osen, Franziska Pilz, Adriana Przybylla, Corinna Klein, Frank Buchholz, Michael D. Milsom, Marieke A. G. Essers, Stefan B. Eichmueller, Wolf-Karsten Hofmann, Daniel Nowak, Daniel Huebschmann, Michael Hundemer, Christian Thiede, Lars Bullinger, Carsten Mueller-Tidow, Scott A. Armstrong, Andreas Trumpp, Vijay K. Kuchroo, Simon Haas

Summary: Hematopoietic stem and progenitor cells (HSPCs) can effectively eliminate malignant cells through bidirectional interactions with CD4(+) T cells, thereby preventing the onset of hematological cancers.

CELL STEM CELL (2022)

Article Cell Biology

SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines

Tsu-Yang Chao, Theresa Kordass, Wolfram Osen, Stefan B. Eichmueller

Summary: The miRNAs miR-134-3p and miR-224-3p were found to directly interact with the SOX9 gene and inhibit its expression in breast cancer cells. These two miRNAs were down-regulated in breast cancer tissues, suggesting their potential role as tumor suppressors in breast cancer progression.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2023)

Article Oncology

IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells

Niklas Kehl, Michael Kilian, Julius Michel, Tim R. Wagner, Sebastian Uhrig, Alexander Brobeil, Lilli-Sophie Sester, Sven Blobner, Simon Steiger, Michael Hundemer, Niels Weinhold, Karsten Rippe, Stefan Froehling, Stefan B. Eichmueller, Lukas Bunse, Carsten Mueller-Tidow, Hartmut Goldschmidt, Michael Platten, Marc-Steffen Raab, Mirco J. Friedrich

Summary: Multiple myeloma (MM) is a rare and aggressive hematological malignancy, and its classification and evolution can be deciphered by molecular features. IgE type MM is a subtype with a small percentage but poor prognosis, and currently there is limited genetic and immunological data available. In this study, comprehensive analysis at the genomic and immune repertoire level revealed the pathophysiological mechanisms and potential targeted therapy opportunities for IgE type MM.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Oncology

Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model

Laura Hartmann, Wolfram Osen, Oliver L. Eichmueller, Theresa Kordass, Jennifer Furkel, Elke Dickes, Carissa Reid, Jurgen Debus, Stephan Brons, Amir Abdollahi, Mahmoud Moustafa, Stefan Rieken, Stefan B. Eichmueller

Summary: Radiotherapy can activate tumor-specific immune responses in patients and combining carbon ion radiotherapy with immune checkpoint inhibition can reshape the immune cell composition in tumors and induce complete rejection of both irradiated and non-irradiated tumors.

CANCER LETTERS (2022)

Article Oncology

MicroRNAs affecting the susceptibility of melanoma cells to CD8+ T cell-mediated cytolysis

Antonino A. A. Pane, Theresa Kordass, Agnes Hotz-Wagenblatt, Elke Dickes, Annette Kopp-Schneider, Rainer Will, Barbara Seliger, Wolfram Osen, Stefan B. B. Eichmueller

Summary: This study identified several miRNA species that can affect the susceptibility of melanoma cells to T cell-mediated killing. These miRNAs may represent attractive candidates for novel therapy approaches against melanoma and other tumors.

CLINICAL AND TRANSLATIONAL MEDICINE (2023)

Article Immunology

Cognate Interaction With CD4+ T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like Phenotype

David Eisel, Krishna Das, Elke Dickes, Rainer Koenig, Wolfram Osen, Stefan B. Eichmueller

FRONTIERS IN IMMUNOLOGY (2019)

暂无数据